Johnson & Johnson CFO Joseph Wolk on Covid-19 study pause

The study of Johnson & Johnson's Covid-19 vaccine has been paused due to an unexplained illness in a study participant. Johnson & Johnson CFO Joseph Wolk joins "Squawk Box" to discuss.
04:29
Tue, Oct 13 20207:29 AM EDT